Immucell Corp /De/
ImmuCell develops colostrum-derived oral antibody products for preventing scours (neonatal calf diarrhea) in calves.
10-QAug 13Latest SEC filing, period to Jun 30
Aug 13Latest story
August 2026
July 2026
ImmuCell develops colostrum-derived oral antibody products for preventing scours (neonatal calf diarrhea) in calves.